The effect of magnesium supplementation on hyperandrogenism,sleep quality and hirsutism in women with polycystic ovary syndrome

Not Applicable

Recruiting

• Conditions: polycystic ovarian syndrome.; Polycystic ovarian syndrome; E28.2

• Registration Number: IRCT20130903014551N8
• Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 6 October 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 70

Inclusion Criteria

Women over 18 and under 45 years old
BMI between 18/5 to 30
Do not change the dose of the drug or start taking a new drug in the last two weeks
Absence of menopause
Taking vitamin and mineral supplements

Exclusion Criteria

Failure to follow nutritional recommendations and interventions
Do not refer the person again in the next steps
Change the dose of the drug or start taking a new drug that affects the study indicators
Use of Minoxidil
Having a specific disease that disrupts the study process
Occurrence of menopause

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Hyperandrogenism. Timepoint: Before and after the intervention. Method of measurement: Measurement of serum concentrations of testosterone and dehydroepiandrosterone sulfate.;Hirsutism. Timepoint: Before and after the intervention. Method of measurement: Modified Ferriman-Gallwey questionnaire.;Sleep quality. Timepoint: Before and after the intervention. Method of measurement: Petersburg sleep quality questionnaire.

Secondary Outcome Measures

Name	Time	Method
Magnesium. Timepoint: Before and after the intervention. Method of measurement: Serum magnesium.